Deliverable Volume

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE5288.6096.2 (+1.85 %)
PREV CLOSE ( ) 5192.40
OPEN PRICE ( ) 5199.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 258
TODAY'S LOW / HIGH ( )5184.95 5299.00
52 WK LOW / HIGH ( )3102 7208
NSE5285.1085.15 (+1.64 %)
PREV CLOSE( ) 5199.95
OPEN PRICE ( ) 5198.00
BID PRICE (QTY) 5285.10 (9)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5299
TODAY'S LOW / HIGH( ) 5168.95 5304.90
52 WK LOW / HIGH ( )3098 7220.95
Exchange
Period From  
Period To  
Date Total Volume Deliverable Volume Deliverable Volume (%)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.